REGULATED PRESS RELEASE published on 01/16/2024 at 07:01, 2 years 8 months ago bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D bioMérieux, a world leader in in vitro diagnostics, announces the appointment of two new Executive Committee members, Dr. Charles K. Cooper and Céline Roger-Dalbert, to lead Medical Affairs and Research & Development, respectively. Dr. Cooper brings extensive medical and leadership background from Siemens Healthcare Diagnostics and U.S. Food & Drug Administration, while Céline Roger-Dalbert boasts over 25 years of in vitro diagnostic experience, with significant contributions to new product launches and over 20 patent applications. Their nominations signify bioMérieux's commitment to addressing global patients' needs and driving innovation, aligning with the company's strategy. For more information, visit www.biomerieux.com. BioMérieux Medical Affairs Research And Development In Vitro Diagnostics Executive Committee Members
REGULATED PRESS RELEASE published on 01/08/2024 at 08:22, 2 years 8 months ago bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions. BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
REGULATED PRESS RELEASE published on 10/26/2023 at 07:01, 2 years 11 months ago bioMérieux – Third-Quarter 2023 Business Review
REGULATED PRESS RELEASE published on 10/19/2023 at 08:00, 2 years 11 months ago bioMérieux makes strategic investment in Oxford Nanopore
REGULATED PRESS RELEASE published on 10/13/2023 at 07:02, 2 years 11 months ago bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion
Published on 10/01/2026 at 23:05, 27 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 1 hour 32 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/01/2026 at 19:05, 4 hours 27 minutes ago PEL 90 Participating Interest Exchange with Chevron
Published on 10/01/2026 at 18:05, 5 hours 27 minutes ago Bocana Resources Corp. Provides a Corporate Update on Various Projects Currently Underway
Published on 10/01/2026 at 15:28, 8 hours 4 minutes ago Core Critical Metals Corp. Announces Shareholder Approval of Plan of Arrangement
Published on 10/01/2026 at 23:15, 16 minutes ago CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 2 hours 47 minutes ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 3 hours 2 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 4 hours 37 minutes ago Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios
Published on 10/01/2026 at 19:00, 4 hours 32 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 4 hours 51 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 5 hours 27 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 10/01/2026 at 18:00, 5 hours 31 minutes ago Saint-Gobain completes the acquisition of Xypex (North America), a leader in high value-added waterproofing solutions
Published on 10/01/2026 at 17:55, 5 hours 37 minutes ago Disclosure of transactions in own shares from September 28 to September 30, 2026